FXS is determined by mutations in the FMR1 gene (fragile X messenger ribonucleoprotein 1 gene; OMIM 309550), located on Xq27.3, where the folate-sensitive fragile site FRAXA was initially described in affected males. This evidence concerns the gene FMR1 and fragile X syndrome.